Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma

BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is a difficult to treat tumor with a poor prognosis. Aspartate β-hydroxylase (ASPH) is a highly conserved enzyme overexpressed on the cell surface of both murine and human HCC cells. METHODS: We evaluated therapeutic effects of nanoparticle lambda...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwagami, Yoshifumi, Casulli, Sarah, Nagaoka, Katsuya, Kim, Miran, Carlson, Rolf I., Ogawa, Kosuke, Lebowitz, Michael S., Fuller, Steve, Biswas, Biswajit, Stewart, Solomon, Dong, Xiaoqun, Ghanbari, Hossein, Wands, Jack R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619992/
https://www.ncbi.nlm.nih.gov/pubmed/28971150
http://dx.doi.org/10.1016/j.heliyon.2017.e00407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619992/
https://www.ncbi.nlm.nih.gov/pubmed/28971150
http://dx.doi.org/10.1016/j.heliyon.2017.e00407

Ejemplares similares